VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as C$0.09 and last traded at C$0.09, with a volume of 197364 shares trading hands. The stock had previously closed at C$0.09.
VentriPoint Diagnostics Trading Down 5.6 %
The firm’s 50-day moving average price is C$0.10 and its 200-day moving average price is C$0.14. The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56. The company has a market cap of C$13.79 million, a P/E ratio of -2.63 and a beta of 0.39.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Stories
- Five stocks we like better than VentriPoint Diagnostics
- How to Short Nasdaq: An Easy-to-Follow Guide
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- What Are Treasury Bonds?
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
